FBRX

Forte Biosciences Inc

• Seeking Alpha·06/03 10:58

  At a glance: stocks gapping up premarket

• TipRanks·06/02 21:52

  Forte Biosciences Shareholders Approve Directors and Governance Items

• Benzinga·06/02 20:49

  Forte Biosciences Files $500M Shelf Registration For Potential Issuance Of Common Stock, Preferred Stock, Debt Securities, Warrants, And Other Securities From Time To Time

• Reuters·06/02 20:40

  FORTE BIOSCIENCES - MAY OFFER UP TO $500 MLN IN SECURITIES - SEC FILING

• PUBT·06/02 20:02

  Forte Biosciences shareholders approve amended, restated 2021 equity incentive plan at annual meeting

• Seeking Alpha·05/16 05:55

  Forte Biosciences: Targeting Celiac Disease

• TipRanks·05/11 21:50

  Analysts Are Bullish on Top Healthcare Stocks: Aktis Oncology, Inc. (AKTS), Metagenomi, Inc. (MGX)

• TipRanks·05/11 20:25

  Forte Biosciences: Buy Rating Backed by FB102 Pipeline Momentum and Multiple Upcoming Clinical Catalysts

• PUBT·05/11 20:01

  Forte Biosciences grants new hire options, RSUs covering 100,000 shares

• Reuters·05/11 20:01

  FORTE BIOSCIENCES, INC. REPORTS INDUCEMENT GRANT UNDER NASDAQ LISTING RULES

• TipRanks·05/11 14:15

  Forte Biosciences reports Q1 EPS ($1.24), consensus ($1.16)

• Reuters·05/11 13:10

  CORRECTED-Forte Biosciences Q1 net loss widens as R&D spending rises

• Reuters·05/11 13:10

  Forte Biosciences Q1 net loss narrows as R&D spending rises

• Seeking Alpha·05/11 13:10

  Forte Biosciences GAAP EPS of -$1.24

• Benzinga·05/11 13:06

  Forte Biosciences Q1 EPS $(1.24) Misses $(1.19) Estimate